Affiliation:
1. Institute of Neurology Azienda Ospedaliero Universitaria di Cagliari Cagliari Italy
2. Department of Medical Sciences and Public Health University of Cagliari Cagliari Italy
3. Department of Translational Biomedicine and Neurosciences University of Bari "Aldo Moro" Bari Italy
Abstract
AbstractObjectiveSeveral studies have demonstrated a higher frequency of seizures and epilepsy in Alzheimer's disease and other forms of dementia as compared with healthy elderly individuals. However, incidence and prevalence of epilepsy in the general population of dementia are unknown since most previous studies were performed in secondary‐tertiary referral centres. In addition, all prior studies but one provided “period” rather than “point” prevalence estimates.MethodsWe assessed point prevalence estimate of epileptic manifestations requiring antiepileptic medication in patients Alzheimer's disease, vascular dementia, and fronto‐temporal dementia from a secondary clinical setting.ResultsPoint prevalence estimates were 6.4% (95% CI: 1.5 to 11.3) in Alzheimer's disease, 8.9% (95% CI: 1.4 to 16.4), in vascular dementia, and 6% (95% CI: 1.3 to 10.7) in fronto‐temporal dementia, rates that were greater than those observed in the healthy elderly population. Regardless of the etiology of dementia, epilepsy was characterized by unprovoked seizures that lacked distinguishing clinical features.SignificanceThese findings support epilepsy as part of the spectrum of dementia. The similar point prevalence of definite epilepsy requiring AED treatment in Alzheimer's disease and non Alzheimer dementias raised the possibility of similar underlying mechanism of epileptogenesis. Although this was not a population‐based study, accurate point prevalence data from clinic setting would be important to better define the burden of epilepsy in dementia and the demands on health services to manage the condition.